The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity.
Agrawal NG, Matthews CZ, Mazenko RS, Woolf EJ, Porras AG, Chen X, Miller JL, Michiels N, Wehling M, Schultz A, Gottlieb AB, Kraft WK, Greenberg HE, Waldman SA, Curtis SP, Gottesdiener KM.
Agrawal NG, et al. Among authors: gottlieb ab.
J Clin Pharmacol. 2004 Oct;44(10):1125-31. doi: 10.1177/0091270004268129.
J Clin Pharmacol. 2004.
PMID: 15342613
Clinical Trial.